Utah Medical Products Holds Annual Stockholder Meeting

TL;DR

UTMD stockholders met May 3rd and approved proposals. Business as usual.

AI Summary

Utah Medical Products, Inc. held its annual meeting of stockholders on May 3, 2024. During this meeting, the stockholders approved the matters submitted for their vote. The company's principal executive offices are located at 7043 South 300 West, Midvale, Utah.

Why It Matters

This filing confirms that the company's stockholders have voted on and approved matters presented at the annual meeting, indicating ongoing corporate governance and operational continuity.

Risk Assessment

Risk Level: low — The filing reports on routine corporate governance matters, specifically the outcome of a stockholder vote at an annual meeting, which typically carries low inherent risk.

Key Players & Entities

• UTAH MEDICAL PRODUCTS, INC. (company) — Registrant
• May 3, 2024 (date) — Date of annual meeting of stockholders
• 7043 South 300 West, Midvale, Utah 84047 (location) — Principal executive offices

FAQ

Filing Documents

• utmd-20240503.htm (8-K) — 17KB
• 0001096906-24-001026.txt ( ) — 140KB
• utmd-20240503_def.xml (EX-101.DEF) — 2KB
• utmd-20240503_lab.xml (EX-101.LAB) — 20KB
• utmd-20240503_pre.xml (EX-101.PRE) — 13KB
• utmd-20240503.xsd (EX-101.SCH) — 2KB
• utmd-20240503_htm.xml (XML) — 2KB

07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS On May 3, 2024 at the Company's annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration: Elected Kevin L. Cornwell as a director of the Company: For 1,436,389 Withheld 1,304,680 Broker Non Votes 324,644 Elected Paul O. Richins as a director of the Company: For 907,483 Withheld 1,833,586 Broker Non Votes 324,644 Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2024: For 3,012,801 Against 49,443 Abstentions 3,469 Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,662,106 Against 72,899 Abstentions 6,064 Broker Non Votes 324,644 Per Company policy, Mr. Richins tendered his resignation, which was conditioned upon acceptance by the Board of Directors. The Board of Directors voted not to accept his resignation. Per Utah law, Mr. Richins was elected to serve a three-year term and until his successor is elected and qualified. The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials. Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. REGISTRANT Date: 5/03/2024 By: /s/ Kevin L. Cornwell Kevin L. Cornwell Chairman & CEO

View Full Filing

View this 8-K filing on SEC EDGAR